Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - PLUS THERAPEUTICS, INC. | ex31_1.htm |
| 10-K/A - CYTORI THERAPEUTICS, INC 10-K A NO 1 12-31-2013 - PLUS THERAPEUTICS, INC. | form10ka.htm |
EXHIBIT 31.2
Certification of Principal Financial Officer Pursuant to
Securities Exchange Act Rule 13a-14(a)
As Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Mark E. Saad, certify that:
|
1.
|
I have reviewed this annual report on Form 10-K of Cytori Therapeutics, Inc.;
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
|
Date: April 29, 2014
|
|
|
/s/ Mark E. Saad
|
|
|
Mark E. Saad,
|
|
|
Chief Financial Officer
|
|